Time to get proper diagnosis in multiple sclerosis and start disease-modifying therapy: the Highlands MS incidence study

被引：0
|
作者：
Artal, F. J. Carod [1 ]
机构：
[1] Raigmore Hosp, NHS Highlands, Neurol Dept, Inverness, Scotland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1354
引用
收藏
页码：769 / 770
页数：2
相关论文
共 50 条
  • [41] Multiple Sclerosis Management: Current Clinical Approaches to Disease-Modifying Therapy
    Appleberry, Holly C.
    Shin, Robert K.
    CURRENT PHYSICAL MEDICINE AND REHABILITATION REPORTS, 2022, 10 (03) : 140 - 144
  • [42] Health insurance affects the use of disease-modifying therapy in multiple sclerosis
    Wang, Guoqiao
    Marrie, Ruth Ann
    Salter, Amber R.
    Fox, Robert
    Cofield, Stacey S.
    Tyry, Tuula
    Cutter, Gary R.
    NEUROLOGY, 2016, 87 (04) : 365 - 374
  • [43] Discontinuation of first-line disease-modifying therapy in multiple sclerosis
    Coerver, E. M.
    Bourass, A.
    Wessels, M. H.
    Van Kempen, Z. L.
    Jasperse, B.
    Barkhof, F.
    Mostert, J.
    Uitdehaag, B. M.
    Killestein, J.
    Strijbis, E. M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 338 - 338
  • [44] Health economics of disease-modifying therapy for multiple sclerosis in the United States
    Hartung, Daniel M.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [45] Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
    F. Schweitzer
    S. Laurent
    G. R. Fink
    Michael H. Barnett
    H. P. Hartung
    C. Warnke
    Journal of Neurology, 2021, 268 : 2379 - 2389
  • [46] Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis
    MacDonald, Sarah C.
    McElrath, Thomas F.
    Hernandez-Diaz, Sonia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (04) : 556 - 560
  • [47] Factors Affecting the Adherence to Disease-Modifying Therapy in Patients With Multiple Sclerosis
    Erbay, Oznur
    Yesilbalkan, Oznur Usta
    Yuceyar, Nur
    JOURNAL OF NEUROSCIENCE NURSING, 2018, 50 (05) : 291 - 297
  • [48] Multiple Sclerosis Management: Current Clinical Approaches to Disease-Modifying Therapy
    Holly C. Appleberry
    Robert K. Shin
    Current Physical Medicine and Rehabilitation Reports, 2022, 10 : 140 - 144
  • [49] Examining the Effects of Comorbidities on Disease-Modifying Therapy Use in Multiple Sclerosis
    Zhang, Tingting
    Tremlett, Helen
    Leung, Stella
    Zhu, Feng
    Kingwell, Elaine
    Fisk, John
    Bhan, Virender
    Campbell, Trudy
    Yu, Nancy
    Marrie, Ruth-Ann
    NEUROLOGY, 2016, 86
  • [50] Cost-Sharing and Initiation of Disease-Modifying Therapy for Multiple Sclerosis
    Romley, John
    Goldman, Dana
    Eber, Michael
    Dastani, Home
    Kim, Edward
    Raparla, Swetha
    AMERICAN JOURNAL OF MANAGED CARE, 2012, 18 (08): : 460 - 464
12345